Published in Drug Week, January 10th, 2003
Under the terms of this agreement, which is for an initial 5 years, Actelion will be the marketing license holder and will be responsible for all regulatory and marketing activities and for booking sales of Zavesca. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.